Pharmaceuticals

Chickenpox Vaccine Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Chickenpox Vaccine Industry In 2025?

The chickenpox vaccine market size has experienced robust expansion in recent years. This market is set to expand from $3.57 billion in 2024 to $3.76 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.5%. Historically, this growth can be ascribed to advancements in vaccine development, successful regulatory approvals, the occurrence of the disease, established vaccination policies, and various public health initiatives.

The market for chickenpox vaccines is anticipated to experience robust expansion over the coming years. It is projected to reach $4.82 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the forecast period include public confidence and belief, readiness for pandemics, ongoing research and development efforts, increasing demand from developing markets, and advancements in healthcare infrastructure. Key trends foreseen for this period encompass educational initiatives for vaccines, diligent monitoring of adverse events, strategic approaches to vaccine pricing, advanced technological innovation, and the integration of artificial intelligence.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8581&type=smp

Which Drivers Are Shaping The Chickenpox Vaccine Industry’s Market Share?

The increasing occurrence of chickenpox disease is anticipated to boost the expansion of the chickenpox vaccine market in the future. Chickenpox is defined as a serious contagious illness, triggered by the varicella-zoster virus (VZV), characterized by a fluid-filled and itchy rash. A higher number of chickenpox cases requires greater varicella vaccine immunization, consequently escalating the demand for chickenpox vaccines. To illustrate, a report from October 2023 by the National Library of Medicine (NLM), a US-based biomedical library, indicated that a study examining GP consultations for chickenpox between September 2016 and December 2022 revealed an average weekly rate of 3.4 per 100,000 people in England, consistently peaking from weeks 13 to 15 annually. During the COVID-19 pandemic, the usual epidemic peaks did not occur, probably attributable to social distancing measures and lockdowns. Nevertheless, in 2022, the frequency of consultations was elevated among children under 1 year old relative to years prior to the pandemic, suggesting altered transmission dynamics. Consequently, the increasing prevalence of chickenpox disease is fueling the expansion of the chickenpox vaccine market.

What Are The Key Segments In The Chickenpox Vaccine Market?

The chickenpox vaccine market covered in this report is segmented –

1) By Vaccine: Monovalent Varicella Vaccine, Combination Varicella Vaccine

2) By Application: Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immunization, Chickenpox Vaccination

3) By End-Users: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Monovalent Varicella Vaccine: Live Attenuated Varicella Vaccine

2) By Combination Varicella Vaccine: Measles, Mumps, Rubella, And Varicella (MMRV) Vaccine

What Are The Latest Industry Trends Transforming The Chickenpox Vaccine Market?

The development of novel drugs represents the primary trend gaining popularity within the chickenpox vaccine market. Key companies in the market are engaged in creating new drugs featuring improved efficacy and innovative derivatives, among other advancements, to sustain their competitive standing. For instance, in November 2022, Sinovac Biotech Ltd., a China-based company focused on vaccine research, development, and manufacturing, announced that its live attenuated chickenpox (varicella) vaccine received prequalification from the World Health Organization (WHO). This made it the world’s first varicella vaccine to achieve such prequalification. The varicella vaccine is derived from the Oka strain and produced in SINOVAC’s unique Human Diploid Cell (SV-1 strain). This cell is developed through the cultivation and harvesting of the virus, followed by the addition of stabilizers and freeze-drying. A phase III efficacy trial showed that the seroconversion rate in the vaccine-administered children group, aged 1 to 12 years, was 97.1%. The vaccine’s efficacy against varicella was 87.1%, and against breakthrough varicella, it was 89.2%. Additionally, the vaccine offers 100 percent defense against both mild and serious conditions.

Which Leading Players Are Enhancing Their Chickenpox Vaccine Market Presence Worldwide?

Major companies operating in the chickenpox vaccine market include Merck & Co., Sanofi Pasteur, Takeda Pharmaceutical Company Limited, CSL Limited, Pfizer Inc., Seqirus, Serum Institute of India Pvt. Ltd., Bharat Biotech, Emergent BioSolutions Inc., Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co., Ltd., Chongqing Zhifei Biological Products Co., Ltd., Beijing Minhai Biotechnology Co., Ltd., Adimmune Corporation, Biological E. Limited, Walvax Biotechnology Co., Ltd., Zydus Cadila, Indian Immunologicals Ltd., Panacea Biotec Ltd., Bio Farma, PT Kalbe Farma Tbk, CanSino Biologics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Which Region Currently Holds The Largest Share Of The Chickenpox Vaccine Market?

North America was the largest region in the chickenpox vaccine market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chickenpox vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chickenpox Vaccine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8581&type=smp

Browse Through More Reports Similar to the Global Chickenpox Vaccine Market 2025, By The Business Research Company

Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Dtp Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795